Personensuche
X
?
1
Ethics approved protocol:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.s002. , 2023
doi:10.1371/journal.pone.0294519.s002. , 2023
?
2
S1 File -:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.s004. , 2023
doi:10.1371/journal.pone.0294519.s004. , 2023
?
3
SPIRIT checklist:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.s001. , 2023
doi:10.1371/journal.pone.0294519.s001. , 2023
?
4
Primary outcomes for the IVA POP trial:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.t005. , 2023
doi:10.1371/journal.pone.0294519.t005. , 2023
?
5
SPIRIT diagram representing the proposed schedule of enrolm..:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.g001. , 2023
doi:10.1371/journal.pone.0294519.g001. , 2023
?
6
Intravenous acetaminophen for postoperative pain in the neo..:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659208/?tool=EBI. , 2023
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659208/?tool=EBI. , 2023
?
7
Using the RE-AIM framework to evaluate the feasibility of a..:
Daniel Briatico ; Kristen C. Reilly ; Patricia Tucker...
https://doi.org/10.1186/s40814-023-01248-8. , 2023
https://doi.org/10.1186/s40814-023-01248-8. , 2023
?
8
IV Acetaminophen dosing guidelines for the IVA POP trial:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.t002. , 2023
doi:10.1371/journal.pone.0294519.t002. , 2023
?
9
Demographic variables for IVA POP trial:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.t004. , 2023
doi:10.1371/journal.pone.0294519.t004. , 2023
?
10
Major abdominal and thoracic operations as defined by the C..:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.s003. , 2023
doi:10.1371/journal.pone.0294519.s003. , 2023
?
11
Secondary clinical outcomes for the IVA POP trial:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.t007. , 2023
doi:10.1371/journal.pone.0294519.t007. , 2023
?
12
Secondary feasibility outcomes for the IVA POP trial:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.t006. , 2023
doi:10.1371/journal.pone.0294519.t006. , 2023
?
13
Time parameters for postoperative day designation for the I..:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.t003. , 2023
doi:10.1371/journal.pone.0294519.t003. , 2023
?
14
Inclusion and exclusion criteria for the IVA POP trial:
Victoria Anne Archer ; Samira Samiee-Zafarghandy ; Forough Farrokyhar...
doi:10.1371/journal.pone.0294519.t001. , 2023
doi:10.1371/journal.pone.0294519.t001. , 2023
?
15
Using the RE-AIM framework to evaluate the feasibility of a..:
Briatico, Daniel ; Reilly, Kristen C ; Tucker, Patricia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009980/. , 2023
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009980/. , 2023